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Introduction 
 
Many human foodborne illnesses are 
caused by pathogens commonly harbored by 
food animals.  Escherichia coli O157 is one of 
these pathogens commonly isolated from beef 
cattle feces and can enter the food chain at 
harvest.  In addition to the human health con-
cerns, this pathogen has important economic 
implications.  Costly recalls of beef products 
and loss of consumer confidence associated 
with outbreaks of foodborne illness can affect 
profitability on many levels of production.  In 
the past 10 years, E. coli O157 has cost the 
beef industry an estimated $2.67 billion.  A 
portion of this expense is allocated to govern-
ment and industry research.  Methods to inter-
vene and reduce the opportunity of these 
pathogens to enter the food chain have been 
tested and implemented both pre- and post-
harvest.  The focus of this experiment was to 
evaluate the effectiveness of a novel vaccine 
technology to reduce E. coli O157 shedding in 
feeder cattle prior to harvest. 
 
A relatively new vaccine technology de-
veloped by Epitopix (Wilmar, MN) targets 
pathogenic bacteria based on their inherent 
requirement for iron. Vaccines developed with 
this technology target siderophore receptor 
and porin proteins (SRP) of specific bacteria 
and disrupt their iron transport systems, which 
ultimately causes death of the organisms.  Pre-
liminary experiments have shown that SRP 
vaccines reduce fecal shedding of Salmonella 
Newport and E. coli O157 in experimentally 
infected mice.  In two experiments involving 
experimentally infected cattle, an SRP vaccine 
for E. coli O157 reduced fecal shedding of the 
experimental strain of E. coli O157.  Given 
the success of this vaccine in cattle challenged 
with E. coli O157, the objective of the current 
experiment was to test the efficacy of the E. 
coli O157 SRP vaccine in feedlot cattle natu-
rally infected with E. coli O157. 
 
Experimental Procedures 
 
 A population consisting of approximately 
600 feedlot heifers was screened for the pres-
ence of E. coli O157 in the feces.  Cattle posi-
tive for fecal shedding of E. coli O157 were 
re-sampled to confirm shedding. At re-
sampling, an additional procedure was in-
cluded to identify animals that were shedding 
the organism at abnormally high levels (super-
shedders).  Sixty cattle were selected from the 
original population for use in this study.  Fifty 
of these 60 animals were fecal positive for E. 
coli O157 on two occasions and the remaining 
10 animals were fecal positive on one occa-
sion.  Cattle were stratified based on results of 
fecal shedding of E. coli O157 in screening 
samples and randomly allotted, within strata, 
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to one of three treatment groups (20 ani-
mals/treatment): 1) control, 2) vaccinated on 
day 0 and 21 with 2 cc with SRP E. coli vac-
cine, or 3) vaccinated on day 0 and 21 with 3 
cc of SRP E. coli O157 vaccine.  Cattle were 
housed in one of three barns containing 20 
individual feeding pens.  Animals were allo-
cated to pens in treatment blocks within each 
barn to eliminate sharing of waterers across 
treatments and reduce animal-to-animal con-
tact across treatments.  Waterers were cleaned 
three times weekly to reduce the potential of 
these as a transmission vector.  Cattle were fed 
a standard feedlot receiving diet (Table 1) 
once daily. 
 
 
Table 1.  Ingredient Composition and 
Nutrient Content of the Experimental Diet
Ingredients: 
Percent of Diet 
(DM basis) 
 Steam-flaked corn 50.3% 
 Alfalfa hay 40.0% 
 Corn steep liquor 4.0% 
 Premix 5.7% 
  
Nutrients:  
 NEm 0.83 Mcal/lb 
 NEg 0.55 Mcal/lb 
 CP 14.5% 
 Ca 0.70% 
 P 0.33% 
 Ca:P 2.1:1 
 
 
Fecal samples and rectoanal mucosal swab 
samples were collected two or three times a 
week for 8 weeks to monitor shedding of E. 
coli O157.  Precautions were taken to reduce 
the potential for sample contamination chute 
side.  Detection of E. coli O157 was by selec-
tive enrichment, immunomagnetic separation, 
and plating on selective agar.  Biochemical 
and antigenic tests were also used for further 
confirmation.  Procedures to identify super-
shedders were also performed on fecal sam-
ples. Briefly, pre-enriched samples were 
streaked onto selective agar in triplicate and if 
two or three of these plates had confirmed E. 
coli O157 colonies present, the animal of 
sample origin was considered a super-shedder. 
 
Results and Discussion 
 
 Overall, average E. coli O157 prevalence 
across all sampling days in the feedlot heifers 
was 9.3% as detected by rectoanal mucosal 
swab (RAMS) culture, 10.9% as detected by 
fecal culture, and 15.8% as detected by either 
RAMS or fecal culture.  A previous study per-
formed one year earlier with similar type cat-
tle in the same facility with similar procedures 
found an average prevalence of 50%.  Because 
prevalence was lower than expected, data 
were analyzed as repeated measures on ani-
mals over weeks instead of sampling days to 
increase prevalence, and barn was included as 
a random effect.  Overall prevalence of E. coli 
O157 in cattle receiving placebo, 2 ml vac-
cine, and 3 ml vaccine was 33.7%, 29.1%, and 
17.7% (Figure 1).  Treatment also reduced the 
number of days that animals were found posi-
tive for E. coli O157, with a significant differ-
ence in pair-wise comparison of placebo vs 3 
ml vaccine treatments (P = 0.08; Figure 2).   
 
Modeling efforts by other researchers re-
vealed that 80% of natural transmission of E. 
coli O157 in a cattle population is attributed to 
20% of infections in which animals are shed-
ding the organism at abnormally high levels.  
Reducing the number of animals shedding at 
high levels would be an important outcome of 
pre-harvest intervention strategies. In the cur-
rent experiment, the number of animals identi-
fied as super-shedders on one or more sam-
pling days was reduced by vaccine treatment 
(P = 0.08; Figure 3).  Again, pair-wise com-
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parison of placebo and 3 ml vaccine treat-
ments revealed that the vaccine was effica-
cious in reducing the percentage of E. coli su-
per-shedders in feeder cattle.  These differ-
ences may give insight into proper dosage of 
the vaccine for efficacy in naturally infected 
cattle. 
Implications 
 
 The E. coli O157 SRP vaccine reduced 
prevalence and the number of days that cattle 
shed E. coli O157 and there is evidence that 
the vaccine decreases the number of cattle 
shedding high levels of the organism. 
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Figure 1. Percent of Animals Testing 
Postitive for E. coli O157 on Sampling 
Weeks by Treatment Group. 
 
Super-shedders 
0
5
10
15
20
Least Squares Means
A
ni
m
al
s
3 ml vaccine 2 ml vaccine Placebo
P=0.30
P=0.08
Vaccine effect: P=0.19 (F test)
 
E. coli  O157 Positive Days
0
2
4
6
8
10
Least Squares Means
D
ay
s
3 ml vaccine 2 ml vaccine Placebo
P=0.50
P=0.02
Vaccine effect: P=0.15 (F test)
Figure 2.  Least Squares Means of the 
Number of Days Animals were Found Posi-
tive for E. coli O157 by Treatment.  Data 
were analyzed with a general linear model. 
 
Figure 3. Least Squares Means by Treat-
ment of the Number of Animals Detected 
as Super-shedders on One or More Sam-
pling Days.  Data were analyzed with a gen-
eral linear model. 
 
